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Highlights 
 
 This is a systematic review of all RCTs on physical activity, fast-mimicking diet 
and psychological interventions that have evaluated survival outcomes in all 
cancers.   
 Long-term psychological therapies in primary and/or adjuvant treatment settings 
have demonstrated potential to improve survival. 
 The effects of fast-mimicking diet on cancer survival has not been evaluated to 
date. 
 Well-designed and sufficiently powered RCTs are needed to evaluate the survival 
benefits of physical activities and psychological and behavioural therapies in 
cancer. 
 
Abstract 
Background: 
Health professionals are often asked if non-pharmacological interventions prolong 
life. This review aims to evaluate the effects of physical activity, fast-mimicking diet 
(FMD) and psychological interventions on survival in all cancers. 
Methods: A systematic review and meta-analysis of randomized controlled trials 
(RCTs). Only RCTs of physical activity, FMD and psychological interventions 
(including counselling, cognitive and other psychotherapies) in cancer patients that 
reported survival outcomes were included. 
Data sources: CENTRAL, MEDLINE, Embase, CINAHL, APA PsycINFO, Web of 
Science, ICTRP and ClinicalTrials.gov from inception to January 2020 were searched 
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without language restrictions. The protocol was prospectively registered at 
PROSPERO (CRD42019160944). 
Results: 
Thirty-one RCTs (9 on physical activity and 22 on psychological interventions) were 
included in the final analysis after evaluation of 60,207 records from our initial 
search. No eligible RCT on FMD was reported. RCTs on group psychological 
interventions (41.9%) and in patients with breast cancer (38.7%) were the most 
common. Most evaluated short-term interventions and in primary or adjuvant 
settings. Only one of 9 (11%) RCTs on physical activity and 8 of 22 (36%) RCTs on 
psychological interventions were associated with improved overall survival. Only 
group psychological interventions in breast cancer had adequate number of RCTs to 
allow a meta-analysis to be performed. It demonstrated a trend towards improved 
overall survival (HR -0.20, 95%CI -0.49 to 0.10), particularly in RCTs that evaluated 
long-term (>6 months) therapies (HR -0.29, 95%CI -0.59 to 0.01). 
Conclusion:  
Longer term interventions starting early in the patients’ care journey in primary and 
adjuvant settings have shown the most promise for improving survival. Better 
designed RCTs including survival outcomes are particularly needed in non-breast 
cancers.  
 
Keywords: systematic review; neoplasm; physical activity; psychotherapy; 
behavioural therapy 
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1. Background 
Earlier diagnosis and improved treatments have significantly prolonged 
cancer survival rates in most cancers.1-3 Research on survivorship recognizes 
patients with cancers require multidisciplinary support to rehabilitate and return to 
normal life.2, 4 Interventions to support cancer survivorship do not only improve 
quality of life (QoL),2, 4-8 but also have the potential to improve survival (e.g. through 
secondary prevention of disease recurrence or separate primary cancers).8-11 
Non-pharmacological and non-invasive interventions play key roles in 
supporting patients with cancers, and patients are often keen to know if these 
interventions prolong life.1, 2, 12 However, few RCTs have focused on evaluating 
survival outcomes, which are sometimes assessed as a secondary outcome without 
sufficient power in individual studies to detect potentially significant differences.2, 4 
Attempts have been made to review high-quality evidence of selected dietary 
interventions for cancer survivors,5, 6 but few reviews have focused on their impact 
on survival outcomes.1, 5, 6, 8, 12, 13 A recent Cochrane review by Burden and co-
workers8 concluded that dietary interventions had no significant benefit on survival in 
adult cancer survivors. However, despite recent evidence suggesting the benefits of 
fasting-mimicking diets (FMDs) on modifying metabolic health and risks of cancers,14 
this Cochrane review8 did not include the potential use of FMDs as a dietary 
intervention to improve outcomes. 
The levels of physical activity have been associated with better cancer 
prognosis in multiple tumour types in observational studies.10, 11 However, specific 
interventions to increase physical activity have not consistently demonstrated 
survival benefits in patients with cancer, especially in RCTs.15 Moreover, promoting 
long-term adoption of any behavioural and psychological intervention is 
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challenging.13 Similarly, psychological interventions have been shown to improve 
fatigue16 and QoL5, 6, 12, 17 in patients with cancers, but their influence on survival 
outcomes have not been thoroughly investigated in different cancer types.5, 6, 12, 17  
 In this systematic review and meta-analysis, we aimed to assess all reported 
RCTs that had evaluated the effectiveness of physical activity, FMD and 
psychological interventions on improving survival in patients with cancers. 
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2. Methods 
This systematic review and meta-analysis was performed in accordance with 
the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA).18 The protocol was prospectively registered at the International 
Prospective Register of Systematic Reviews (PROSPERO) registry 
(CRD42019160944). 
 
2.1. Inclusion and exclusion criteria- patients 
Only RCTs that had aimed to evaluate the effects of physical activity, FMD 
and psychological interventions in adults with confirmed diagnoses of cancers were 
included. 
In addition, only RCTs that evaluated overall survival (OS) and/or disease-free 
survival (DFS), defined as the interval between successful treatment and the time to 
progression of the cancer treated (for RCTs in primary/adjuvant settings), and/or 
progression-free survival, defined as the interval from diagnosis to the date of 
progression of their cancers (i.e., time to progression; for RCTs in metastatic 
setting). When possible, hazard ratio of death was used as the summary measure 
for comparison. 
 
2.2. Inclusion and exclusion criteria- interventions 
Physical activity was not limited to exercise, and include other activities 
involving body movements that are done as part of playing, working, active 
transportation, household chores and recreational activities. All psychological 
interventions, such as mindfulness, counselling, cognitive behavioural therapy and 
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psychoeducation, were included. There are no limitations on the setting, duration 
and delivery of these interventions. 
RCTs included patients who were receiving additional experimental 
pharmacological and/or invasive adjuvant treatments, which were not the standards 
of care for their malignancies, were excluded. 
 
2.3. Comparators 
Comparators are the control groups in the included trial. Types of controls 
were divided into “usual care” and “alternative care” groups in the quantitative 
analysis, representing studies comparing an intervention to usual care and 
alternative interventions, respectively. 
 
2.4. Outcomes 
The primary outcomes are OS, PFS and DFS. 
 
2.5. Information sources and search 
The literature search was conducted in January 2020 and updated in March 
2020. The search was carried out on the following databases from inception to 
present: Cochrane Central Register of Controlled Trials (CENTRAL) via the 
Cochrane Library; MEDLINE(R) and Embase via Ovid; the Cumulative Index to 
Nursing and Allied Health Literature (CINAHL) and APA PsycINFO using 
EBSCOhost; Web of Science Core Collection; the WHO International Clinical Trials 
Registry Platform Portal (ICTRP); and ClinicalTrials.gov. Both text words and 
indexing related to cancer, survival, physical activity, FMD and psychological 
interventions were used. The Scottish Intercollegiate Guidelines Network (SIGN) 
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randomized controlled trials search filter was adjusted for each database. One 
reviewer (PC) developed the search strategies, which were reviewed by EYLL, and 
conducted the search. The full search strategies are available as a supplementary 
document (Supplementary document 1). 
We also performed further searches to ensure all relevant material were 
found, including hand-searches of the reference lists of the selected papers and 
searches of the grey literature (via OpenGrey and WorldCat). No language 
restrictions were imposed. 
 
2.6. Study selection 
Two researchers (EC and HM) screened the titles retrieved from the literature 
search to determine studies which appeared relevant to the study. Two researchers 
(EC and HM) then assessed abstracts against the inclusion criteria to determine that 
they were eligible for full text analysis. Eligible trials were read in full, and any 
uncertainties with regards to eligibility were resolved by involvement of a third 
researcher (EYLL). Where studies had multiple publications, the trial reports with the 
most comprehensive follow-up data were included as the primary reference and 
additional information was supplemented from the other publications.  
 
2.7. Data extraction and management 
EYLL pre-designed the data extraction form. It was piloted by two 
independent reviewers (EC and HM) and amendments were made after discussions 
with EYLL. EC and HM then used this form to extract data for analysis. Variables 
included the location of the research team, publication date, patient demographics 
(including age, gender, smoking status, performance status, body mass index, 
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ethnicity), survival data (both overall survival and disease-free survival) and a 
summary of other reported outcomes. Data were summarized by all reviewers, a 
graphical summary was generated using Prism (v8.0, GraphPad, La Jolla, CA). 
Meta-analysis, assessments of heterogeneity and risks of biases were performed 
using STATA® Version 16 (StataCorp, USA). 
 
2.8. Assessment of risk of bias in included studies 
The risks of bias of each study for measuring survival outcomes were 
assessed by the revised Cochrane risk-of-bias tool for randomized trials (RoB 2) and 
presented in Supplementary Figure 1.19 Sensitivity analysis was performed to 
evaluate the influence of studies at high risks of bias on the results of the meta-
analysis. 
 
2.9. Measures of treatment effects  
The timing of interventions was prospectively divided into three treatment 
groups, 1) primary treatments - interventions started before and during patients’ 
primary curative treatments for their cancers; 2) adjuvant treatments- interventions 
for patients who were in remission (i.e. disease-free) following their primary cancer 
treatments; 3) palliative treatment- interventions for patients with advanced and/or 
metastatic diseases. In addition, studies were evaluated by the type of interventions 
and by cancer type. Short-term interventions were defined as interventions that were 
less than or equal to 6 months.  
Meta-analysis and relevant sensitivity analyses were performed by the type of 
interventions and cancer type when there were sufficient RCTs. To account for 
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statistical heterogeneity, the random-effects restricted maximum likelihood (REML) 
model was used.  
When hazard ratios were not reported, reported time-to-event data were used 
to estimate hazard ratios, using established methods described by Tierney and co-
workers.20 Forrest plots of hazard ratios were generated using STATA® Version 16 
(StataCorp, USA). Funnel plot was used to assess publication bias, and tested by 
using the Egger’s test. Sensitivity analyses were performed to evaluate the influence 
of studies with high risks of bias and the different types of controls used in the 
included studies.   
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3. Results 
3.1. Study selection 
Figure 1 represents the PRISMA flow diagram. In total, 60,207 references 
were retrieved and full text of 67 studies were further assessed for eligibility; 36 were 
excluded as they did not satisfy one or more of the inclusion criteria. Thirty-one 
studies (9 on physical activity and 22 on psychological interventions) met the 
inclusion criteria. No eligible RCT on fast-mimicking diet in cancer was identified. 
Nine studies were included in the meta-analyses from 10 suitable RCTs (one did not 
provide sufficient time-to-event data to estimate hazard ratios21). Studies excluded 
after full-text assessments are summarized in Supplementary Table 1. 
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Figure 1: PRISMA flow diagram of this systematic review 
 
3.2. Study characteristics 
 Key features of the included studies (n=31) are summarized in Figure 2. 
RCTs in patients with breast cancer (38.7%) and on group psychological 
interventions (41.9%) were the most common (Figure 2a-b). In addition, 
psychological interventions were more likely to be tested in palliative care settings 
than physical activity (Figure 2c). The majority evaluated short-term interventions 
(Figure 2d).  
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Figure 2: Key features of the included studies (n=31). a) Number of studies by 
cancer type; b) number of studies by the type of interventions evaluated; c) 
number of studies by the timing of the interventions; d) number of studies by 
the duration of the interventions. Short-term interventions were defined as 
those that were less than or equal to 6 months. 
 
3.3. Survival and other outcomes 
Survival outcomes are summarized in Table 1 and 2. All interventions 
compared to usual care unless otherwise stated in the tables. No PFS was reported 
in the identified RCTs in metastatic setting, hence only DFS rates were summarised. 
Additional outcomes of the reported studies are summarized in Supplementary Table 
2. Only one of 9 (11%) included RCTs on physical activity,22 which investigated a 32-
week individualized aerobic and resistance exercise programme in patients with 
breast cancer, was associated with improved overall survival. In contrast, 8 of 22 
(36%) RCTs on psychological interventions reported improved survival outcomes; 7 
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of 13 (54%) and 1 of 9 (11%) in the primary/adjuvant and palliative settings, 
respectively. Two of 7 (28.6%) individual psychological intervention studies, versus 5 
of 15 (33.3%) group psychological intervention studies, were associated with 
improved survival. All three studies on counselling did not demonstrate improved 
overall survival. One of 6 (16.7%) studies on cognitive therapies, versus 6 of 13 
(46.2%) studies on other psychological interventions, were associated with improved 
survival. 
Other reported outcomes of the included studies are summarized in 
Supplementary Table 2. When reported, the majority of studies reported 
improvements of anxiety, depression and QoL-related outcomes. One study also 
reported shortened length of hospital stay and related costs post-operatively.23 
The identified RCTs were highly heterogenous, and therefore we restricted 
our meta-analysis to only interventions that had previously been evaluated in high 
number of RCTs. Only RCTs investigating psychological interventions in breast 
cancer (n=9) were further evaluated by a meta-analysis because of the limited 
numbers of eligible RCTs in other groups (Figure 3). In total, 1687 participants were 
included in this analysis (667 in studies of short-term interventions and 1018 in 
studies of long-term interventions). Although there was no overall statistical 
difference in hazard ratios in patients who received these interventions (-0.20; 95% 
CI -0.49 to 0.10), a trend towards improved survival was observed particularly in 
RCTs that evaluated long-term (>6 months) interventions (-0.29; 95% CI -0.59 to 
0.01). Further sensitivity analyses suggested that neither studies at high risks of bias 
nor different types of controls influenced the results of the meta-analysis 
(Supplementary Figure 2). 
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First author, 
year 
Cancer 
type; stage 
Settings 
Sample size 
N (I vs C) 
Interventions; duration 
(frequency) 
Survival outcomes 
Physical activity (n=7) 
LaStayo  
201124 
Mixed; 
mixed 
Adjuvant 40 
(20 vs 20) 
Individual resistance 
exercise; 
14 weeks (3 times per week) 
OS: statistical test of difference not reported. I= 
8.5 years vs C= 8.3 years. 
DFS: not reported. 
Yeo 
201225 
GI; 
localized 
Primary 102 
(54 vs 48) 
Individual walking exercise; 
12 weeks (weekly) 
OS: no difference. HR = 1.3 (95% CI 0.7-2.5; 
p=0.560). 
DFS: not reported. 
Courneya 
201426 
Breast; 
localized 
 
Adjuvant 242 
(160 vs 82) 
Individual resistance exercise 
and aerobic exercise; 
12 weeks (3 times per week) 
OS: no difference. HR=0.60 (95%CI 0.27-1.33). 
DFS: no difference. HR=0.68 (95% CI 0.37-1.24). 
Courneya 
201427 
Lymphoma; 
mixed 
Primary 122 
(60 vs 62) 
Group aerobic exercise; 12 
weeks (3 times per week) 
OS: not reported. 
DFS: no difference. HR= 1.06 (95% CI 0.56–2.00; 
p=0.860). 
Karenovics  
201728 
Lung; 
localized 
Primary 151 
(74 vs 77) 
Individual high-intensity 
interval training; 
3 weeks (3 times per week) 
OS: no difference. I= 93.2% vs 90.9% at 1 year; 
p=0.506. 
DFS: not reported. 
Dhillon  
201729 
Lung; mixed Primary 111 
(56 vs 55) 
Individual tailored exercise; 
8 weeks (weekly) 
OS: no difference. Log rank p= 0.75. 
DFS: not reported. 
Hayes 
201722 
Breast; 
localized 
Adjuvant 337 
(207 vs 130) 
Individual aerobic and 
resistance exercises; 
32 weeks (weekly) 
OS: improved. HR=0.45 (95%CI 0.20-0.97; 
p=0.040). 
DFS: HR= 0.66 (95% CI 0.38-1.17; p=0.160). 
Psychological interventions (n=13) 
Fawzy 
199330  
Melanoma; 
localized 
Primary 68 
(34 vs 34) 
Group psychoeducation; 
6 weeks (weekly) 
OS: improved. I=31/34 (91%) vs C: 24/34 (71%) 
survived at 6 years. Log rank p=0.030. 
DFS: I= 30/34 vs C: 31/34 at 6 years. 
Kissane 
200431 
Breast; 
localized 
Adjuvant 303 
(154 vs 149) 
Group cognitive existential 
therapy*; 
20 weeks (weekly) 
OS: no difference. HR 1.35 (95%CI 0.76-2.39; 
p=0.370). 
DFS: not reported. 
Boesen 
200732 
Melanoma; 
localized 
Primary 262 
(131 vs 131) 
Group psychoeducation; 
6 weeks (weekly) 
OS: no difference. HR 1.3 (95%CI 0.5-3.5). 
DFS: no difference. HR 0.73(95%CI 0.3-1.9). 
Küchler 
200733 
GI; 
localized 
Primary 271 
(136 vs 125) 
Individual psychotherapy; 
1 week (not reported) 
OS: improved. HR 0.69 (95%CI 0.52-0.92; 
p=0.013) 
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DFS: not reported 
Andersen 
200834 
Breast; 
localized 
Adjuvant 227 
(114 vs 113) 
Group psychoeducation; 
52 weeks (weekly for 4 
month and monthly for 8 
months) 
OS: improved. HR 0.51 (95%CI 0.28-0.93; 
p=0.028).  
DFS: improved. HR 0.553 (95%CI 0.32-0.96; 
p=0.034). 
Ross  
200935 
GI; 
localized 
Adjuvant 249 
(125 vs 124) 
Individual psychosocial 
intervention; 
24 months (10 visits with 
telephone calls) 
OS: no difference. I: 50/125 (40%) vs C: 52/124 
(41%). Log-rank p=0.69. 
DFS: not reported. 
Boesen 
201121 
Breast; 
localized 
Adjuvant 186 
(89 vs 97) 
Group cognitive existential 
therapy; 
8 weeks (weekly) 
OS: statistical test of difference not reported. 
I=83/89 (93%) vs C= 94/97 (97%). 
DFS: not reported. 
Choi 
20119 
Mixed; 
mixed 
Adjuvant 237 
(118-119) 
Individual cognitive 
behavioural therapy; 
20 weeks (every 2 weeks) 
OS: no difference. HR: 1.07 (95%CI 0.75-1.53; 
p=0.710). 
DFS: not reported. 
Guo 
201336 
Mixed; 
localized 
Adjuvant 178 
(89 vs 89) 
Group psychosocial 
intervention; 
9 weeks (2 times per week) 
OS: no difference. I= 83.1% vs C= 84.3%. Log 
rank p=0.925. 
DFS: no difference. I= 79.8% vs C=76.4%. Log 
rank p=0.527. 
Zhang 
201323 
GI; 
localized 
Primary 60 
(31 vs 29) 
Individual psychoeducation 
intervention; 
3 weeks (3 times per week) 
OS: no difference. I= 64.3% v C=55.6% at 4 years. 
Log rank p=0.446. 
DFS: not reported. 
Stagl 
201537 
Breast; 
localized 
Primary 240 
(120 vs 120) 
Group cognitive behaviour 
therapy**; 
10 weeks (weekly) 
OS: improved. HR 0.21 (95%CI 0.05-0.93; 
p=0.040). 
DFS: no difference. HR 0.45 (95%CI 0.17-1.18; 
p=0.083). 
Bao 
201938 
AML; mixed Adjuvant 220 
(110 vs 110) 
Individual psychoeducation 
intervention; 
12 weeks (weekly) 
OS: improved. HR 0.653 (95%CI 0.43-1.00; 
p=0.045). 
DFS: no difference. HR 0.747 (95%CI 0.54-1.04; 
p=0.071). 
Wang 
201939 
GI; 
localized 
Adjuvant 136 
(68 vs 68) 
Individual psychoeducation 
intervention; 
12 weeks (monthly) 
OS: improved. Median survival- I= 37 (IQR 28-46) 
months vs C= 32 (IQR 27-37) months. Log rank 
p=0.026. 
DFS: not reported 
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All interventions compared to usual care unless otherwise stated. Compared to *3 relaxation classes alone; **Compared to a 1-
day psychoeducational self-help classroom seminar. I= intervention group; C= control group; GI= gastrointestinal; OS= overall 
survival; DFS= disease-free survival. 
 
Table 1: Summary of survival outcomes of all studies in primary/adjuvant settings (n=20)  
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First author, 
year 
Cancer 
type; stage 
Sample size 
N (I vs C) 
Interventions; duration 
(frequency) 
Survival outcomes 
Physical activity (n=2) 
Oldervoll 
201140 
Mixed; 
metastatic 
231 
(121 vs 110) 
Individual tailored exercise; 
8 weeks 
OS: no difference. HR = 1.24 (95% CI 0.90-1.70; p=0.180). 
Rief 
201641 
Mixed; 
metastatic 
60 
(30 vs 30) 
Individual resistance exercise*; 
2 weeks 
 
OS: no difference. HR=0.68, p=0.303. 
Psychological interventions (n=9) 
Linn 
198242 
Mixed; 
metastatic 
120 
(62 vs 58) 
Individual counselling; 
52 weeks (>1 per week) 
OS: statistical test of difference not reported. Mean survival: 
I=3.7 months vs C=4.4 months. 
Spiegel 
198943 
Breast; 
metastatic 
86 
(50 vs 36) 
Group psychosocial therapy; 
52 weeks (weekly) 
OS: improved. Mean survival I=36.6 months vs C= 18.9 
months. Log rank p<0.01. 
Cunningham 
199844 
Breast; 
mixed 
66 
(30 vs 36) 
Group cognitive behavioural 
therapy**; 
35 weeks (weekly) 
OS: no difference. Median survival I=28.2 (95%CI 25.8-51.7) 
months vs C=23.6 (95%CI 18.9-34.9) months. Log rank 
p=0.35. 
Edelman 
199945 
Breast; 
metastatic 
121 
(60 vs 61) 
Group cognitive behavioural 
therapy; 
8 weeks (weekly) 
OS: statistical test of difference not reported. Median survival 
I=11.6 (IQR 7.1-17.5) months vs C=12.8 (IQR 7.56-17.8) 
months. 
Goodwin 
200146 
Breast; 
metastatic 
235 
(158 vs 77) 
Group psychotherapy; 
52 weeks (weekly) 
OS: no difference. HR 1.06 (95%CI 0.78-1.45; p=0.72). 
Kissane 
200747 
Breast; 
metastatic 
227 
(147 vs 80) 
Group psychotherapy***; 
52 weeks (weekly) 
OS: no difference. HR 0.92 (95%CI 0.69-1.24; p=0.6). 
 
Spiegel 
200748 
Breast; 
metastatic 
125 
(64 vs 61) 
Group psychotherapy****; 
52 weeks (weekly) 
OS: no difference. HR 0.93 (95%CI 0.62-1.40; p=0.73) 
Geerse 
201649 
Lung; mixed 223 
(110 vs 113) 
Individual counselling; 
25 weeks (not stated) 
OS: no difference. Median survival I= 10.3 (95%CI 6.5-14.1) 
months vs C=10.1 (95%CI 7.6-12.6) months. Log rank p=0.62. 
Lloyd Williams 
201850 
Mixed; 
metastatic 
57 
(33 vs 24) 
Individual counselling; 
2 weeks (not stated) 
OS: no difference. Median survival I= 5.2 months vs C= 3.4 
months. Mann Whitney U test p=0.07. 
All interventions compared to usual care unless otherwise stated. Compared to *passive physical therapy; **home study 
cognitive behavioural package; ***3 relaxation classes each lasting 1 hour over 3 weeks; ****self-directed education. I= 
intervention group; C= control group; OS= overall survival. 
 
Table 2: Summary of survival outcomes of all studies in palliative settings (n=11)  
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Figure 3: Forest plot of hazard ratios and 95% confidence intervals of all RCTs 
on psychological interventions in breast cancer by duration of treatment (n=9). 
 
3.4. Assessment of the risks of bias 
The risk of bias assessment of the included studies is summarized in Figure 4 
(assessments of individual studies are summarized in Supplementary Figure 1). 
While all studies had no significant missing data and survival outcome 
measurements, most did not report deviations from intended interventions. Nine of 
the 31 (29%) included studies were deemed to be at high-risk of bias. Blinding was 
not possible in all the RCTs reported. Funnel plot of the studies included in the meta-
analysis and the Egger’s test did not detect significant publication bias 
(Supplementary Figure 2; p= 0.086). 
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Figure 4: Summary of the risks of bias assessment of all included studies (n=31)
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4. Discussion 
4.1. Main findings 
Patients who have survived cancer often seek advice from health 
professionals for additional interventions that could prolong life. This is a 
comprehensive review of all RCTs on physical activity and psychological 
interventions in cancer to evaluate their impact on survival. 
The majority of included RCTs evaluated psychological interventions (22 of 
31, 69%; Figure 2). Physical activity and group psychological interventions had 
previously been recommended in palliative care settings to improve QoL.6, 12, 15, 51 All 
3 included RCTs on counselling (a type of individual psychological intervention) did 
not demonstrate survival benefit. There was no apparent difference between the 
benefits of individual versus group psychological interventions on survival (28.6% 
versus 33.3%; Section 3.3). In this study, improved survival outcomes were identified 
in patients who received early interventions in primary or adjuvant treatment settings. 
Our results suggest that these interventions should be introduced early in a patient’s 
recovery journey (Table 1-2).  
 Our meta-analysis also suggested that longer term psychological 
interventions (>6 months) have the potential to improve survival (Figure 3). Further 
evaluations are warranted to evaluate the positive trends observed and clarify the 
settings in which such interventions could be beneficial. Moreover, there is limited 
evidence from RCTs on the benefits of the evaluated interventions for patients with 
non-breast cancers.  
Despite the increasing popularity of FMDs amongst cancer survivors, no RCT 
on FMDs has reported improved cancer survival outcome.52, 53 A randomized cross-
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over trial of patients with breast and ovarian cancers evaluated QoL and tolerance to 
chemotherapy after short-term FMD during chemotherapy.52 Another more recent 
multi-center Phase 2 RCT on short-term FMD in patients with localized breast cancer 
during neoadjuvant chemotherapy demonstrated safety and potential improvements 
of radiological responses.53 Larger and sufficiently powered RCTs are required to 
evaluate the benefits of fasting in cancers. 
 
4.2. Strengths and limitations 
In contrast to previous reports, we focused on survival outcomes, which has 
not been comprehensively evaluated in previous systematic reviews, and did not 
restrict to RCTs on specific cancer type to allow a broad overview on the effects of 
these interventions on cancer survival.1, 5, 6, 12, 13, 16, 17 In contrast to two recent 
systematic reviews on physical activity,10, 11 our protocol was prospectively 
registered and no date or language restrictions were used. Despite the renewed 
interests on physical activity and psychological therapy for cancer survivors, we only 
identified 31 RCTs that have evaluated these interventions. Due to their 
heterogeneity, we were not able to include most RCTs for meta-analysis. 
  
4.3. Recommendations for future studies  
Survival outcomes are not commonly reported in RCTs on physical activity and 
psychological therapies. This review challenges this omission. Ideally, large RCTs on 
these non-pharmacological interventions should be conducted, but the large sample 
size required is likely to limit the focus on survival outcomes. Core outcome sets 
ensure researchers measure and report those outcomes that are most likely to be 
relevant to users of their research.54 By including survival outcomes being part of the 
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core outcome set for RCTs on non-pharmacological interventions in cancers, it will 
ensure their reporting and allow meta-analyses of survival outcomes.55-57 
Numerous observational studies and clinical trials on physical activity and 
psychological interventions have been reported.  Psychological interventions have 
been demonstrated to significantly reduce fear of cancer recurrence,58, fatigue16 and 
other patient-reported psychological outcomes.59 These studies also suggested 
larger beneficial effects were associated with shorter follow-up periods, 
complementing our results suggesting longer-term interventions demonstrated a 
trend towards larger survival benefits. Consistent with this study, interventions 
around the time of primary treatment of cancer has previously been shown to reduce 
distress and anxiety, as well as systemic inflammatory response.60 Other factors, 
including age59 and type58 of  psychological interventions, are likely to contribute to 
the potential benefits of these interventions. Moreover, the majority of studies 
evaluated face-to-face interventions- other methods of delivery remain under-
explored.58, 59 To comprehensively evaluate the effectiveness of these therapies, 
concerted efforts to perform well-designed and sufficiently powered RCTs are 
crucial, especially in non-breast cancers. Future studies should consider the timing 
of interventions and characteristics related to patients and interventions when 
designing their protocols.  
 
4.4. Conclusions 
 In summary, this systematic review evaluated all RCTs on physical activity 
and psychological interventions in cancers that had reported survival outcomes. 
Longer term interventions starting early in the patients’ care journey in primary and 
adjuvant settings have shown the most promise for improving survival. FMDs require 
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further evaluation in RCTs to assess their benefits in improving oncological 
outcomes. Well-designed and sufficiently powered RCTs are needed to evaluate the 
benefits of physical activity and psychological interventions, particularly in non-breast 
cancers. 
 
Abbreviations: 
DFS: disease-free survival 
RCT: randomized controlled trial 
FMD: fasting-mimicking diet 
QoL: quality of life 
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
PROSPERO: Prospective Register of Systematic Reviews 
CENTRAL: Cochrane Central Register of Controlled Trials 
CINAHL: the Cumulative Index to Nursing and Allied Health Literature the WHO 
ICTRP: International Clinical Trials Registry Platform Portal 
SIGN: The Scottish Intercollegiate Guidelines Network 
OS: overall survival 
PFS: progression-free survival 
RoB 2: Cochrane risk-of-bias tool for randomized trials 
REML: random-effects restricted maximum likelihood 
 
 
 
 
 
Jo
ur
na
l 
re
-p
ro
of
 
 
25 
Author Statement 
EYLL contributed to the conception of the research question and drafted this 
manuscript. EC and HM contributed to the conception of the research questions and 
acted as reviewers. PC developed and conducted the searches. All authors have 
contributed to this manuscript. 
 
Declarations 
Ethics approval and consent to participate 
This is a systematic review of primary studies. Further ethical approval is not 
required. 
Consent for publication 
All authors have given their consent to publish. No patient identifying details 
are included.  
Competing interest 
No financial and non-financial competing interests to declare. 
 
Funding 
EYLL’s salary is funded by the National Institute for Health Research (NIHR) 
and she is supported by a research grant from the Cancer Research UK (CRUK 
Grant Reference: A28146). 
 
Availability of data and materials 
The dataset supporting the conclusions of this article is included within the 
article and its additional files. 
 
Jo
ur
na
l P
re
-p
ro
of
 
 
26 
Authors’ contributions 
EYLL contributed to the conception of the research question and drafted this 
manuscript. EC and HM contributed to the conception of the research questions and 
acted as reviewers. PC developed and conducted the searches. All authors have 
contributed to this manuscript. 
 
Acknowledgements: 
None. 
 
Legend headings for supplementary figures: 
Supplementary Figure 1: Risk of Bias assessments (RoB 2)19 of all included studies 
Supplementary Figure 2: a) Sensitivity analysis- analysis after excluding studies at 
high risks of bias; b) Sensitivity analysis- by type of control; c) assessment of 
publication bias 
Supplementary Table 1: Papers excluded after full-text assessment 
Supplementary Table 2: Other reported outcomes unrelated to survival of the 
reported studies (n=31) 
Supplementary document: Search strategy used in this systematic review 
 
Jo
ur
na
l P
re
-p
ro
of
 
 
27 
Reference 
1. Cheng KKF, Lim YTE, Koh ZM, Tam WWS. Home‐based multidimensional 
survivorship programmes for breast cancer survivors. Cochrane Database of 
Systematic Reviews. 2017(8). 
2. McCanney J, Winckworth-Prejsnar K, Schatz A, Nardi E, Dwyer A, Lieu C, et 
al. Addressing Survivorship in Cancer Care. Journal of the National 
Comprehensive Cancer Network J Natl Compr Canc Netw. 2018;16(7):801-6. 
3. Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, et 
al. Cancer treatment and survivorship statistics, 2019. CA: A Cancer Journal 
for Clinicians. 2019;69(5):363-85. 
4. Nekhlyudov L, Ganz PA, Arora NK, Rowland JH. Going Beyond Being Lost in 
Transition: A Decade of Progress in Cancer Survivorship. Journal of clinical 
oncology : official journal of the American Society of Clinical Oncology. 
2017;35(18):1978-81. 
5. Galway K, Black A, Cantwell M, Cardwell CR, Mills M, Donnelly M. 
Psychosocial interventions to improve quality of life and emotional wellbeing 
for recently diagnosed cancer patients. Cochrane Database of Systematic 
Reviews. 2012(11). 
6. Jassim GA, Whitford DL, Hickey A, Carter B. Psychological interventions for 
women with non‐metastatic breast cancer. Cochrane Database of Systematic 
Reviews. 2015(5). 
7. Fong DYT, Ho JWC, Hui BPH, Lee AM, Macfarlane DJ, Leung SSK, et al. 
Physical activity for cancer survivors: meta-analysis of randomised controlled 
trials. BMJ. 2012;344:e70. 
8. Burden S, Jones DJ, Sremanakova J, Sowerbutts AM, Lal S, Pilling M, et al. 
Dietary interventions for adult cancer survivors. Cochrane Database of 
Systematic Reviews. 2019(11). 
9. Choi J, Kuo CW, Sikorskii A, You M, Ren D, Sherwood PR, et al. Cognitive 
behavioral symptom management intervention in patients with cancer: 
survival analysis. Supportive care in cancer. 2012;20(6):1243‐50. 
10. McTiernan A, Friedenreich CM, Katzmarzyk PT, Powell KE, Macko R, 
Buchner D, et al. Physical Activity in Cancer Prevention and Survival: A 
Systematic Review. Medicine & Science in Sports & Exercise. 2019;51(6). 
11. Friedenreich CM, Stone CR, Cheung WY, Hayes SC. Physical Activity and 
Mortality in Cancer Survivors: A Systematic Review and Meta-Analysis. JNCI 
Cancer Spectrum. 2019;4(1). 
12. Mustafa M, Carson‐Stevens A, Gillespie D, Edwards AGK. Psychological 
interventions for women with metastatic breast cancer. Cochrane Database of 
Systematic Reviews. 2013(6). 
13. Turner RR, Steed L, Quirk H, Greasley RU, Saxton JM, Taylor SJC, et al. 
Interventions for promoting habitual exercise in people living with and beyond 
cancer. Cochrane Database of Systematic Reviews. 2018(9). 
14. Wei M, Brandhorst S, Shelehchi M, Mirzaei H, Cheng CW, Budniak J, et al. 
Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, 
and cardiovascular disease. Science Translational Medicine. 
2017;9(377):eaai8700. 
15. O’Connell N, Mansfield L, Kay T, Fortune J, Kanya L, Grigsby-Duffy L, et al. 
The relationship between healthy lifestyle behaviours and outcomes for 
Jo
ur
al
Pr
e-
pr
oo
f
 
 
28 
people living with and beyond cancer: an overview of systematic reviews. 
London, United Kingdom.: Brunel University, 2016. 
16. Corbett TK, Groarke A, Devane D, Carr E, Walsh JC, McGuire BE. The 
effectiveness of psychological interventions for fatigue in cancer survivors: 
systematic review of randomised controlled trials. Systematic reviews. 
2019;8(1):324. 
17. Newell SA, Sanson-Fisher RW, Savolainen NJ, For the NSWCCCERP. 
Systematic Review of Psychological Therapies for Cancer Patients: Overview 
and Recommendations for Future Research. JNCI: Journal of the National 
Cancer Institute. 2002;94(8):558-84. 
18. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses: The PRISMA Statement. Annals of 
Internal Medicine. 2009;151(4):264-9. 
19. Sterne J, Savović J, Page M, Elbers R, Blencowe N, Boutron I, et al. RoB 2: a 
revised tool for assessing risk of bias in randomised trials. BMJ. 
2019;366:l4898. 
20. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for 
incorporating summary time-to-event data into meta-analysis. Trials. 
2007;8(1):16. 
21. Boesen EH, Karlsen R, Christensen J, Paaschburg B, Nielsen D, Bloch IS, et 
al. Psychosocial group intervention for patients with primary breast cancer: A 
randomised trial. European Journal of Cancer. 2011;47(9):1363-72. 
22. Hayes SC, Steele M, Spence R, Pyke C, Saunders C, Bashford J, et al. Can 
exercise influence survival following breast cancer: results from a randomised, 
controlled trial. Journal of clinical oncology. 2017;35(15). 
23. Zhang XD, Zhao QY, Fang Y, Chen GX, Zhang HF, Zhang WX, et al. 
Perioperative comprehensive supportive care interventions for chinese 
patients with esophageal carcinoma: a prospective study. Asian Pacific 
journal of cancer prevention: APJCP. 2013;14(12):7359-66. 
24. LaStayo P, Marcus R, Dibble L, Smith S, Beck S. Eccentric exercise versus 
usual-care with older cancer survivors: the impact on muscle and mobility--an 
exploratory pilot study. BMC Geriatr. 2011;11:5. 
25. Yeo TP, Burrell SA, Sauter PK, Kennedy EP, Lavu H, Leiby BE, et al. A 
Progressive Postresection Walking Program Significantly Improves Fatigue 
and Health-Related Quality of Life in Pancreas and Periampullary Cancer 
Patients. Journal of the American College of Surgeons. 2012;214(4):463-75. 
26. Courneya KS, Segal RJ, McKenzie DC, Dong H, Gelmon K, Friedenreich CM, 
et al. Effects of exercise during adjuvant chemotherapy on breast cancer 
outcomes. Med Sci Sports Exerc. 2014;46(9):1744-51. 
27. Courneya KS, Friedenreich CM, Franco-Villalobos C, Crawford JJ, Chua N, 
Basi S, et al. Effects of supervised exercise on progression-free survival in 
lymphoma patients: an exploratory follow-up of the HELP Trial. Cancer 
Causes Control. 2015;26(2):269-76. 
28. Karenovics W, Licker M, Ellenberger C, Christodoulou M, Diaper J, Bhatia C, 
et al. Short-term preoperative exercise therapy does not improve long-term 
outcome after lung cancer surgery: a randomized controlled study. Eur J 
Cardiothorac Surg. 2017;52(1):47-54. 
29. Dhillon HM, Bell ML, van der Ploeg HP, Turner JD, Kabourakis M, Spencer L, 
et al. Impact of physical activity on fatigue and quality of life in people with 
Jo
ur
na
l 
e-
pr
oo
f
 
 
29 
advanced lung cancer: A randomized controlled trial. Annals of Oncology. 
2017;28(8):1889-97. 
30. Fawzy FI, Fawzy NW, Hyun CS, Elashoff R, Guthrie D, Fahey JL, et al. 
Malignant melanoma. Effects of an early structured psychiatric intervention, 
coping, and affective state on recurrence and survival 6 years later. Arch Gen 
Psychiatry. 1993;50(9):681-9. 
31. Kissane DW, Love A, Hatton A, Bloch S, Smith G, Clarke DM, et al. Effect of 
cognitive-existential group therapy on survival in early-stage breast cancer. 
Journal of Clinical Oncology. 2004;22(21):4255-60. 
32. Boesen EH, Boesen SH, Frederiksen K, Ross L, Dahlstrøm K, Schmidt G, et 
al. Survival after a psychoeducational intervention for patients with cutaneous 
malignant melanoma: a replication study. Journal of Clinical Oncology. 
2007;25(36):5698-703. 
33. Küchler T, Bestmann B, Rappat S, Henne-Bruns D, Wood-Dauphinee S. 
Impact of psychotherapeutic support for patients with gastrointestinal cancer 
undergoing surgery: 10-year survival results of a randomized trial. Journal of 
Clinical Oncology. 2007;25(19):2702-8. 
34. Andersen BL, Yang HC, Farrar WB, Golden-Kreutz DM, Emery CF, Thornton 
LM, et al. Psychologic intervention improves survival for breast cancer 
patients: a randomized clinical trial. Cancer. 2008;113(12):3450‐8. 
35. Ross L, Frederiksen K, Boesen SH, Karlsen RV, Rasmussen MS, Sørensen 
LT, et al. No effect on survival of home psychosocial intervention in a 
randomized study of Danish colorectal cancer patients. Psycho-Oncology. 
2009;18(8):875-85. 
36. Getz G, Gabriel SB, Cibulskis K, Lander E, Sivachenko A, Sougnez C, et al. 
Integrated genomic characterization of endometrial carcinoma. Nature. 
2013;497(7447):67-73. 
37. Stagl J, Lechner S, Carver C, Bouchard L, Gudenkauf L, Jutagir D, et al. A 
randomized controlled trial of cognitive-behavioral stress management in 
breast cancer: survival and recurrence at 11-year follow-up. Psycho-
Oncology. 2015;24:86-7. 
38. Bao H, Chen Y, Li M, Pan L, Zheng X. Intensive patient's care program 
reduces anxiety and depression as well as improves overall survival in de 
novo acute myelocytic leukemia patients who underwent chemotherapy: a 
randomized, controlled study. Translational cancer research. 2019;8(1):212‐
27. 
39. Wang J, Yan C, Fu A. A randomized clinical trial of comprehensive education 
and care program compared to basic care for reducing anxiety and 
depression and improving quality of life and survival in patients with 
hepatocellular carcinoma who underwent surgery. Medicine. 
2019;98(44):e17552. 
40. Oldervoll LM, Loge JH, Lydersen S, Paltiel H, Asp MB, Nygaard UV, et al. 
Physical exercise for cancer patients with advanced disease: a randomized 
controlled trial. Oncologist. 2011;16(11):1649-57. 
41. Rief H, Bruckner T, Schlampp I, Bostel T, Welzel T, Debus J, et al. 
Resistance training concomitant to radiotherapy of spinal bone metastases – 
survival and prognostic factors of a randomized trial. Radiation Oncology. 
2016;11(1):97. 
J
ur
na
l P
r
-p
ro
of
 
 
30 
42. Linn MW, Linn BS, Harris R. Effects of counseling for late stage cancer 
patients. Cancer. 1982;49(5):1048-55. 
43. Spiegel D, Bloom JR, Kraemer HC, Gottheil E. Effect of psychosocial 
treatment on survival of patients with metastatic breast cancer. Lancet 
(london, england). 1989;2(8668):888‐91. 
44. Cunningham AJ, Edmonds CVI, Jenkins GP, Pollack H, Lockwood GA, Warr 
D. A randomized controlled trial of the effects of group psychological therapy 
on survival in women with metastatic breast cancer. Psycho-Oncology. 
1998;7(6):508-17. 
45. Edelman S, Lemon J, Bell DR, Kidman AD, Edelman S, Lemon J, et al. 
Effects of group CBT on the survival time of patients with metastatic breast 
cancer. Psycho-Oncology. 1999;8(6):474-81. 
46. Goodwin PJ, Leszcz M, Ennis M, Koopmans J, Vincent L, Guther H, et al. The 
effect of group psychosocial support on survival in metastatic breast cancer. 
New England Journal of Medicine. 2001;345(24):1719-26. 
47. Kissane DW, Grabsch B, Clarke DM, Smith GC, Love AW, Bloch S, et al. 
Supportive-expressive group therapy for women with metastatic breast 
cancer: survival and psychosocial outcome from a randomized controlled trial. 
Psycho-Oncology. 2007;16(4):277-86. 
48. Spiegel D, Butler LD, Giese-Davis J, Koopman C, Miller E, DiMiceli S, et al. 
Effects of supportive-expressive group therapy on survival of patients with 
metastatic breast cancer: A randomized prospective trial. Cancer. 
2007;110(5):1130-8. 
49. Geerse OP, Hoekstra-Weebers J, Stokroos MH, Burgerhof JGM, Groen HJM, 
Kerstjens HAM, et al. Structural distress screening and supportive care for 
patients with lung cancer on systemic therapy: a randomised controlled trial. 
European journal of cancer. 2017;72:37‐45. 
50. Lloyd-Williams M, Shiels C, Ellis J, Abba K, Gaynor E, Wilson K, et al. Pilot 
randomised controlled trial of focused narrative intervention for moderate to 
severe depression in palliative care patients: DISCERN trial. Palliative 
Medicine. 2018;32(1):206-15. 
51. O’Connell N, Mansfield L, Kay T, Fortune J, Kanya L, Grigsby-Duffy L, et al. A 
systematic overview of reviews of the effectiveness and cost effectiveness of 
interventions to promote healthy lifestyle behaviours in people living with or 
beyond cancer. London, United Kingdom: Brunel University, 2016. 
52. Bauersfeld SP, Kessler CS, Wischnewsky M, Jaensch A, Steckhan N, Stange 
R, et al. The effects of short-term fasting on quality of life and tolerance to 
chemotherapy in patients with breast and ovarian cancer: a randomized 
cross-over pilot study. BMC Cancer. 2018;18(1):476. 
53. de Groot S, Lugtenberg RT, Cohen D, Welters MJP, Ehsan I, Vreeswijk MPG, 
et al. Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for 
breast cancer in the multicentre randomized phase 2 DIRECT trial. Nature 
communications. 2020;11(1):3083. 
54. Kirkham JJ, Gorst S, Altman DG, Blazeby JM, Clarke M, Tunis S, et al. Core 
Outcome Set-STAndardised Protocol Items: the COS-STAP Statement. 
Trials. 2019;20(1):116. 
55. Geerse OP, Wynia K, Kruijer M, Schotsman MJ, Hiltermann TJN, Berendsen 
AJ. Health-related problems in adult cancer survivors: development and 
J
ur
al 
Pr
-p
ro
of
 
 
31 
validation of the Cancer Survivor Core Set. Supportive Care in Cancer. 
2017;25(2):567-74. 
56. Nekhlyudov L, Mollica MA, Jacobsen PB, Mayer DK, Shulman LN, Geiger 
AM. Developing a Quality of Cancer Survivorship Care Framework: 
Implications for Clinical Care, Research, and Policy. JNCI: Journal of the 
National Cancer Institute. 2019;111(11):1120-30. 
57. Ramsey I, Corsini N, Hutchinson AD, Marker J, Eckert M. Development of a 
Core Set of Patient-Reported Outcomes for Population-Based Cancer 
Survivorship Research: Protocol for an Australian Consensus Study. JMIR 
Res Protoc. 2020;9(1):e14544. 
58. Tauber NM, O’Toole MS, Dinkel A, Galica J, Humphris G, Lebel S, et al. 
Effect of Psychological Intervention on Fear of Cancer Recurrence: A 
Systematic Review and Meta-Analysis. Journal of Clinical Oncology. 
2019;37(31):2899-915. 
59. Cillessen L, Johannsen M, Speckens AEM, Zachariae R. Mindfulness-based 
interventions for psychological and physical health outcomes in cancer 
patients and survivors: A systematic review and meta-analysis of randomized 
controlled trials. Psycho-Oncology. 2019;28(12):2257-69. 
60. Treanor C, Kyaw T, Donnelly M. An international review and meta-analysis of 
prehabilitation compared to usual care for cancer patients. J Cancer Surviv. 
2018;12(1):64-73. 
61. Guo Z, Tang HY, Li H, Tan SK, Feng KH, Huang YC, et al. The benefits of 
psychosocial interventions for cancer patients undergoing radiotherapy. 
Health Qual Life Outcomes. 2013;11:121. 
Jo
ur
na
l P
re
-p
ro
f
